Dupilumab monoclonal antibody drug. Targets alpha subunit of interleukin-4 receptor and is indicated for the treatment of atopic eczema. Generic name
Dupilumab monoclonal antibody drug. Targets alpha subunit of interleukin-4 receptor and is indicated for the treatment of atopic eczema. Generic name and stylized antibody.
Size: 9000px × 5059px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: antibody, atopic, biological, biosimilar, biotech, biotechnology, breakthrough, disease, drug, dupilumab, eczema, il-13, il-4, immunoglobulin, immunology, inflammation, infusion, injection, inn, interleukin, mab, monoclonal, nomenclature, peptide, protein, receptor, skin
